Evidence

Evidence & method

OXALIA's performance is assessed against a public, comparable, and verifiable methodology — never a marketing promise.

Methodology

Every performance figure will be published with its calculation method: dataset used, annotation protocol, inter-observer comparison. No figure is shared without this basis.

Sensitivity

Let nothing through

—

Figure to be published with its method

Specificity

No false alarms

—

Figure to be published with its method

Productivity gain

Time given back to the radiologist

—

Figure to be published with its method

Regulatory status

OXALIA is not currently CE-marked or FDA-cleared. Rather than hide that fact, we publish our path as it gets confirmed.

Current status
A clinical decision-support solution under development, not marketed as a certified medical device.
Date to be confirmed
CE marking
Building the technical file for CE marking.
Date to be confirmed
Clinical validation
Validation study at a pilot site, together with our institutional partners.
Date to be confirmed